Decrease in Serum Anti-MAG Autoantibodies Is Associated With Therapy Response in Patients With Anti-MAG Neuropathy: Retrospective Study.
Pascal HänggiButrint AliuKea MartinRuben HerrendorffAndreas Johann SteckPublished in: Neurology(R) neuroimmunology & neuroinflammation (2021)
The retrospective analysis confirmed the hypothesis that a relative reduction in serum anti-MAG IgM antibodies is associated with a clinical response to immunotherapies; a sustained reduction of at least 50% compared with pretreatment titers or levels could be a valuable indicator for therapeutic response.